Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] was reported 25241 times

Drugs of the Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VASCULAR MALFORMATION 45 0.2143
1 PARANASAL CYST 45 0.1852
2 MEDICATION OVERUSE HEADACHE 131 0.1530
3 IIIRD NERVE PARESIS 25 0.1374
4 CORONARY ARTERY DISSECTION 63 0.0733
5 MIGRAINE WITHOUT AURA 20 0.0667
6 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 123 0.0622
7 MASTOIDITIS 55 0.0561
8 SKIN CANDIDA 25 0.0479
9 CLUSTER HEADACHE 56 0.0409
10 VASOSPASM 31 0.0337
11 ARTERIOSPASM CORONARY 115 0.0286
12 RENAL APLASIA 20 0.0284
13 RENAL INFARCT 40 0.0276
14 DRUG SPECIFIC ANTIBODY 37 0.0270
15 PRINZMETAL ANGINA 26 0.0261
16 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 65 0.0244
17 MIGRAINE 2275 0.0238
18 PULMONARY ARTERY STENOSIS CONGENITAL 16 0.0219
19 DRUG-DISEASE INTERACTION 16 0.0218
20 DEVICE DEPLOYMENT ISSUE 275 0.0215
21 CENTRAL OBESITY 15 0.0203
22 PITUITARY TUMOUR BENIGN 32 0.0196
23 FOETAL HEART RATE ABNORMAL 17 0.0184
24 ABORTION MISSED 23 0.0181
25 MICROCEPHALY 23 0.0179
26 CLONUS 48 0.0175
27 COLITIS ISCHAEMIC 118 0.0175
28 MIGRAINE WITH AURA 47 0.0173
29 CEREBRAL VENOUS THROMBOSIS 30 0.0165
30 BRUGADA SYNDROME 17 0.0164
31 ENDOMETRIOSIS 74 0.0155
32 CLEFT LIP AND PALATE 17 0.0152
33 AURA 28 0.0150
34 INFECTION REACTIVATION 17 0.0148
35 BINGE EATING 16 0.0148
36 GESTATIONAL HYPERTENSION 19 0.0147
37 OTITIS MEDIA 48 0.0145
38 SECONDARY ADRENOCORTICAL INSUFFICIENCY 21 0.0139
39 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 18 0.0133
40 ANTIBODY TEST POSITIVE 22 0.0132
41 PRE-EXISTING CONDITION IMPROVED 81 0.0130
42 INTRUSIVE THOUGHTS 15 0.0127
43 HYPERTENSIVE EMERGENCY 15 0.0127
44 SMALL FOR DATES BABY 63 0.0127
45 APPLICATION SITE WARMTH 16 0.0125
46 ANGLE CLOSURE GLAUCOMA 32 0.0125
47 TENSION HEADACHE 53 0.0123
48 SEROTONIN SYNDROME 231 0.0120
49 LABELLED DRUG-DRUG INTERACTION ISSUE 17 0.0117
50 OBSTRUCTIVE SLEEP APNOEA SYNDROME 17 0.0117
51 NIPPLE PAIN 23 0.0113
52 STRESS CARDIOMYOPATHY 65 0.0112
53 NASAL DISCHARGE DISCOLOURATION 15 0.0109
54 RESPIRATORY DISORDER NEONATAL 17 0.0105
55 SWOLLEN TONGUE 327 0.0105
56 HYPERREFLEXIA 36 0.0103
57 OLIGOHYDRAMNIOS 34 0.0102
58 PRODUCT PHYSICAL ISSUE 199 0.0099
59 FOETAL GROWTH RESTRICTION 59 0.0097
60 NASAL OEDEMA 17 0.0094
61 HYPOSPADIAS 19 0.0091
62 MAJOR DEPRESSION 66 0.0090
63 RENAL TUBULAR ACIDOSIS 19 0.0087
64 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 28 0.0084
65 THROAT TIGHTNESS 224 0.0083
66 VARICELLA ZOSTER VIRUS INFECTION 17 0.0082
67 LICHEN PLANUS 19 0.0082
68 OESOPHAGEAL SPASM 15 0.0081
69 DISORGANISED SPEECH 15 0.0081
70 MATERNAL EXPOSURE DURING BREAST FEEDING 33 0.0081
71 PHARYNGEAL SWELLING 78 0.0080
72 NARCOLEPSY 15 0.0079
73 DEPRESSIVE SYMPTOM 28 0.0079
74 REBOUND ACID HYPERSECRETION 24 0.0079
75 FEAR OF DEATH 17 0.0076
76 SOMNAMBULISM 48 0.0073
77 ANGIOEDEMA 313 0.0071
78 POST-TRAUMATIC STRESS DISORDER 47 0.0070
79 SUICIDAL BEHAVIOUR 29 0.0070
80 IMPAIRED GASTRIC EMPTYING 94 0.0069
81 INFREQUENT BOWEL MOVEMENTS 17 0.0068
82 HYPERACUSIS 25 0.0067
83 TEMPERATURE INTOLERANCE 69 0.0067
84 SELF-INJURIOUS IDEATION 28 0.0067
85 PRODUCT ADMINISTRATION INTERRUPTED 52 0.0066
86 BLOOD IMMUNOGLOBULIN E INCREASED 16 0.0066
87 MACULOPATHY 23 0.0065
88 HYPERPARATHYROIDISM SECONDARY 16 0.0064
89 MUSCLE CONTRACTIONS INVOLUNTARY 22 0.0063
90 NEEDLE ISSUE 182 0.0062
91 SLEEP APNOEA SYNDROME 117 0.0061
92 DRUG INTOLERANCE 582 0.0060
93 TEMPOROMANDIBULAR JOINT SYNDROME 16 0.0060
94 CHOLECYSTITIS CHRONIC 40 0.0060
95 ATRIAL SEPTAL DEFECT 50 0.0060
96 GESTATIONAL DIABETES 28 0.0059
97 HEAD DISCOMFORT 103 0.0058
98 DEPRESSION SUICIDAL 20 0.0058
99 NASAL DISCOMFORT 45 0.0057
100 THERAPEUTIC PRODUCT EFFECT VARIABLE 22 0.0057
101 SWELLING FACE 369 0.0057
102 NEPHROGENIC ANAEMIA 26 0.0056
103 FOETAL DEATH 29 0.0056
104 MOUTH SWELLING 32 0.0055
105 DEVICE FAILURE 84 0.0055
106 MUSCLE TIGHTNESS 89 0.0055
107 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
108 FEELING OF BODY TEMPERATURE CHANGE 32 0.0055
109 INFUSION SITE PRURITUS 17 0.0054
110 IRON DEFICIENCY 24 0.0053
111 DYSPHONIA 312 0.0053
112 ATRIOVENTRICULAR BLOCK FIRST DEGREE 23 0.0053
113 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 291 0.0053
114 FACIAL PARALYSIS 44 0.0052
115 FIBROMYALGIA 124 0.0051
116 OESOPHAGEAL PAIN 20 0.0051
117 SNORING 19 0.0050
118 VENTRICULAR HYPOKINESIA 16 0.0050
119 HYPERPROLACTINAEMIA 32 0.0049
120 OPTIC ISCHAEMIC NEUROPATHY 19 0.0049
121 DEVICE ISSUE 440 0.0049
122 MONOPLEGIA 21 0.0048
123 PHOTOPHOBIA 89 0.0047
124 FEELING DRUNK 35 0.0047
125 ENURESIS 19 0.0047
126 MENINGITIS ASEPTIC 21 0.0047
127 MUSCLE TWITCHING 106 0.0046
128 RESTLESS LEGS SYNDROME 83 0.0046
129 EAR PRURITUS 16 0.0046
130 NECK PAIN 252 0.0045
131 AUTOIMMUNE THYROIDITIS 17 0.0045
132 TRISMUS 23 0.0044
133 BRUXISM 24 0.0044
134 PRE-ECLAMPSIA 21 0.0044
135 TEARFULNESS 19 0.0044
136 DISTURBANCE IN ATTENTION 238 0.0044
137 CONCUSSION 34 0.0044
138 THERAPY PARTIAL RESPONDER 68 0.0044
139 ACUTE CORONARY SYNDROME 36 0.0043
140 MICTURITION DISORDER 15 0.0043
141 PARAESTHESIA ORAL 62 0.0043
142 PAIN IN JAW 121 0.0043
143 CHRONIC KIDNEY DISEASE 324 0.0043
144 PERIPHERAL COLDNESS 58 0.0042
145 SINUS TACHYCARDIA 59 0.0042
146 FACIAL PAIN 37 0.0041
147 BIPOLAR DISORDER 45 0.0041
148 FOETAL EXPOSURE DURING PREGNANCY 334 0.0041
149 HYSTERECTOMY 35 0.0040
150 APHASIA 122 0.0040
151 HYPERTONIA 23 0.0040
152 MATERNAL EXPOSURE TIMING UNSPECIFIED 15 0.0040
153 INTENTIONAL DRUG MISUSE 83 0.0040
154 INTRACRANIAL PRESSURE INCREASED 22 0.0039
155 THERAPEUTIC PRODUCT EFFECT DELAYED 18 0.0039
156 NEUTROPENIC SEPSIS 28 0.0039
157 IMPAIRED QUALITY OF LIFE 56 0.0039
158 MELANOCYTIC NAEVUS 17 0.0039
159 PARAESTHESIA 609 0.0039
160 APPLICATION SITE BURN 19 0.0039
161 LIMB DISCOMFORT 119 0.0038
162 TENDERNESS 40 0.0038
163 CHEST DISCOMFORT 393 0.0038
164 TONSILLITIS 20 0.0038
165 UTERINE LEIOMYOMA 28 0.0038
166 RHINITIS ALLERGIC 17 0.0038
167 PHOTOPSIA 24 0.0038
168 NYSTAGMUS 20 0.0038
169 POOR QUALITY SLEEP 81 0.0038
170 MUSCLE SPASTICITY 46 0.0037
171 AFFECT LABILITY 36 0.0037
172 EYELID PTOSIS 38 0.0037
173 HEADACHE 2343 0.0037
174 APPLICATION SITE DISCOLOURATION 15 0.0037
175 VENTRICULAR FIBRILLATION 41 0.0037
176 DRUG SPECIFIC ANTIBODY PRESENT 24 0.0037
177 TROPONIN INCREASED 28 0.0037
178 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63 0.0037
179 FEELING OF DESPAIR 17 0.0036
180 CHOKING SENSATION 20 0.0036
181 TENSION 22 0.0036
182 ACUTE MYOCARDIAL INFARCTION 106 0.0036
183 VITAMIN D DEFICIENCY 35 0.0036
184 FOREIGN BODY IN REPRODUCTIVE TRACT 32 0.0036
185 PHARYNGEAL OEDEMA 55 0.0036
186 TINNITUS 164 0.0036
187 TORSADE DE POINTES 28 0.0036
188 SEASONAL ALLERGY 50 0.0035
189 VERTIGO 215 0.0035
190 ANAL ABSCESS 19 0.0035
191 ABDOMINAL HERNIA 16 0.0035
192 INFUSION SITE SWELLING 22 0.0035
193 BLEPHAROSPASM 22 0.0035
194 VENTRICULAR SEPTAL DEFECT 20 0.0035
195 BODY TEMPERATURE INCREASED 71 0.0035
196 SPUTUM DISCOLOURED 33 0.0035
197 SENSORY LOSS 28 0.0035
198 SKIN ATROPHY 20 0.0035
199 LIVE BIRTH 29 0.0035
200 VISUAL FIELD DEFECT 25 0.0035
201 DRUG USE DISORDER 29 0.0034
202 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
203 BRAIN FOG 54 0.0034
204 NEPHROLITHIASIS 158 0.0034
205 MIDDLE INSOMNIA 64 0.0034
206 EAR DISCOMFORT 35 0.0034
207 HYPERAESTHESIA 28 0.0034
208 EAR PAIN 66 0.0034
209 PALPITATIONS 396 0.0034
210 FEELING COLD 94 0.0034
211 SINUS HEADACHE 20 0.0034
212 COGNITIVE DISORDER 156 0.0033
213 PETIT MAL EPILEPSY 17 0.0033
214 OROPHARYNGEAL DISCOMFORT 30 0.0033
215 INITIAL INSOMNIA 34 0.0033
216 PAROSMIA 25 0.0033
217 HORMONE LEVEL ABNORMAL 16 0.0033
218 LIP SWELLING 109 0.0033
219 DIPLOPIA 85 0.0033
220 METABOLIC DISORDER 19 0.0033
221 INFUSION SITE PAIN 42 0.0033
222 MICTURITION URGENCY 37 0.0032
223 DEVICE DEFECTIVE 56 0.0032
224 PANIC ATTACK 117 0.0032
225 MUSCULOSKELETAL STIFFNESS 281 0.0032
226 DYSARTHRIA 120 0.0032
227 IMPAIRED WORK ABILITY 68 0.0032
228 FORMICATION 22 0.0032
229 SUICIDAL IDEATION 289 0.0032
230 DEPRESSION 716 0.0031
231 SCREAMING 20 0.0031
232 DISSOCIATION 24 0.0031
233 END STAGE RENAL DISEASE 57 0.0031
234 FOOD ALLERGY 24 0.0031
235 HAND FRACTURE 22 0.0031
236 OVARIAN CYST 31 0.0031
237 BREAST PAIN 33 0.0031
238 BRAIN INJURY 31 0.0031
239 INTESTINAL ISCHAEMIA 17 0.0031
240 OPTIC NEURITIS 28 0.0031
241 MOOD SWINGS 98 0.0031
242 PANIC REACTION 22 0.0030
243 UPPER-AIRWAY COUGH SYNDROME 25 0.0030
244 SNEEZING 68 0.0030
245 THERAPEUTIC RESPONSE UNEXPECTED 136 0.0030
246 DRUG DOSE OMISSION 501 0.0030
247 PRODUCT TASTE ABNORMAL 41 0.0030
248 ISCHAEMIC STROKE 54 0.0030
249 PREMATURE LABOUR 17 0.0030
250 EXPOSURE DURING PREGNANCY 185 0.0030
251 OBESITY 47 0.0029
252 MOUTH ULCERATION 62 0.0029
253 DRUG ABUSER 18 0.0029
254 ORAL HERPES 57 0.0029
255 ABORTION SPONTANEOUS 117 0.0029
256 GASTROOESOPHAGEAL REFLUX DISEASE 233 0.0029
257 INJECTION SITE INJURY 16 0.0029
258 MYDRIASIS 37 0.0029
259 PRESYNCOPE 70 0.0029
260 DISCOMFORT 174 0.0028
261 ODYNOPHAGIA 17 0.0028
262 LIGAMENT SPRAIN 28 0.0028
263 EUPHORIC MOOD 29 0.0028
264 ANHEDONIA 74 0.0028
265 IMPAIRED DRIVING ABILITY 32 0.0028
266 HYPERSENSITIVITY 522 0.0028
267 MATERNAL EXPOSURE DURING PREGNANCY 250 0.0028
268 GALLBLADDER DISORDER 50 0.0028
269 ANXIETY 796 0.0028
270 ANAPHYLACTIC REACTION 154 0.0028
271 PARANOIA 48 0.0028
272 EYE MOVEMENT DISORDER 19 0.0028
273 FLANK PAIN 26 0.0028
274 HYPERHIDROSIS 357 0.0028
275 SINUSITIS 284 0.0028
276 MENISCUS INJURY 17 0.0028
277 HYPERLIPIDAEMIA 33 0.0028
278 DRY THROAT 28 0.0028
279 THERAPEUTIC RESPONSE DECREASED 167 0.0028
280 HYPOAESTHESIA 412 0.0027
281 HOT FLUSH 207 0.0027
282 TREMOR 455 0.0027
283 DYSPNOEA EXERTIONAL 103 0.0027
284 NONSPECIFIC REACTION 15 0.0027
285 PRODUCT SUBSTITUTION ISSUE 157 0.0027
286 PARALYSIS 39 0.0027
287 ADRENAL INSUFFICIENCY 33 0.0027
288 INCREASED TENDENCY TO BRUISE 25 0.0027
289 HEMIPARESIS 46 0.0027
290 NEURALGIA 66 0.0027
291 MOOD ALTERED 74 0.0027
292 CHEST PAIN 501 0.0027
293 OSTEOPENIA 41 0.0027
294 DECREASED ACTIVITY 29 0.0027
295 THERAPEUTIC RESPONSE SHORTENED 89 0.0027
296 BREAST MASS 18 0.0027
297 SENSORY DISTURBANCE 43 0.0027
298 GASTROINTESTINAL INFECTION 24 0.0027
299 DEPRESSED MOOD 141 0.0027
300 COORDINATION ABNORMAL 37 0.0026
301 RENAL PAIN 28 0.0026
302 SOMNOLENCE 530 0.0026
303 JOINT STIFFNESS 69 0.0026
304 HELICOBACTER INFECTION 27 0.0026
305 CHOLECYSTECTOMY 30 0.0026
306 NASAL CONGESTION 154 0.0026
307 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 186 0.0026
308 BRAIN OEDEMA 33 0.0026
309 COLD SWEAT 46 0.0026
310 LYMPHOEDEMA 18 0.0026
311 ASTHMA 294 0.0026
312 MYALGIA 441 0.0026
313 AUTOIMMUNE HEPATITIS 18 0.0026
314 HYPOMAGNESAEMIA 36 0.0026
315 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 20 0.0026
316 ROTATOR CUFF SYNDROME 33 0.0026
317 SPINAL PAIN 30 0.0026
318 ABORTION INDUCED 24 0.0025
319 THERAPEUTIC PRODUCT EFFECT DECREASED 114 0.0025
320 GASTROINTESTINAL PAIN 28 0.0025
321 AFFECTIVE DISORDER 20 0.0025
322 PLEURISY 15 0.0025
323 PRODUCT QUALITY ISSUE 343 0.0025
324 EAR INFECTION 67 0.0025
325 HEREDITARY ANGIOEDEMA 27 0.0025
326 BRONCHITIS 185 0.0025
327 ABNORMAL LOSS OF WEIGHT 17 0.0025
328 OBSESSIVE-COMPULSIVE DISORDER 20 0.0025
329 NERVE COMPRESSION 23 0.0025
330 SENSATION OF FOREIGN BODY 21 0.0025
331 DEAFNESS 65 0.0025
332 HIATUS HERNIA 32 0.0025
333 RESPIRATION ABNORMAL 17 0.0025
334 BALANCE DISORDER 213 0.0025
335 THIRST 44 0.0025
336 SPEECH DISORDER 129 0.0025
337 URINARY RETENTION 82 0.0025
338 INSOMNIA 654 0.0025
339 INJURY ASSOCIATED WITH DEVICE 50 0.0025
340 NIGHT SWEATS 79 0.0024
341 CRYING 89 0.0024
342 COELIAC DISEASE 24 0.0024
343 ORAL DISCOMFORT 34 0.0024
344 HEAVY MENSTRUAL BLEEDING 22 0.0024
345 ATAXIA 29 0.0024
346 RED BLOOD CELL SEDIMENTATION RATE INCREASED 27 0.0024
347 SENSITIVE SKIN 18 0.0024
348 BURNING SENSATION 171 0.0024
349 PSYCHOLOGICAL TRAUMA 21 0.0024
350 TACHYCARDIA 216 0.0024
351 ANKYLOSING SPONDYLITIS 32 0.0024
352 CANDIDA INFECTION 41 0.0024
353 CARPAL TUNNEL SYNDROME 34 0.0024
354 EMBEDDED DEVICE 24 0.0024
355 DIZZINESS 1208 0.0024
356 ACUTE HEPATIC FAILURE 33 0.0024
357 SKIN INFECTION 27 0.0024
358 NIGHTMARE 83 0.0024
359 DRY MOUTH 194 0.0024
360 RETINAL HAEMORRHAGE 17 0.0024
361 MUSCULOSKELETAL DISCOMFORT 41 0.0024
362 DRUG INTERACTION 375 0.0024
363 WITHDRAWAL SYNDROME 99 0.0024
364 WRIST FRACTURE 28 0.0023
365 IRRITABLE BOWEL SYNDROME 50 0.0023
366 ABNORMAL FAECES 19 0.0023
367 MUSCLE STRAIN 20 0.0023
368 QUALITY OF LIFE DECREASED 31 0.0023
369 ECONOMIC PROBLEM 35 0.0023
370 HAEMORRHAGIC STROKE 18 0.0023
371 FEELING HOT 141 0.0023
372 EXOSTOSIS 21 0.0023
373 MULTIPLE ALLERGIES 18 0.0023
374 CYSTITIS 73 0.0023
375 VISION BLURRED 314 0.0023
376 FEELING ABNORMAL 547 0.0023
377 INJECTION SITE DISCOMFORT 24 0.0023
378 DERMATITIS CONTACT 26 0.0023
379 DYSGRAPHIA 15 0.0023
380 ANGINA PECTORIS 65 0.0023
381 COMPLICATION OF DEVICE REMOVAL 41 0.0023
382 NAUSEA 1794 0.0023
383 RESPIRATORY TRACT INFECTION 59 0.0023
384 LYMPHOPENIA 32 0.0023
385 MULTIPLE SCLEROSIS RELAPSE 155 0.0023
386 DENTAL CARIES 25 0.0023
387 CENTRAL NERVOUS SYSTEM LESION 31 0.0023
388 PRODUCT DOSE OMISSION 147 0.0022
389 DRY EYE 112 0.0022
390 JOINT RANGE OF MOTION DECREASED 30 0.0022
391 HYPERTENSION 473 0.0022
392 DRUG EFFECT LESS THAN EXPECTED 33 0.0022
393 VOMITING 1047 0.0022
394 INSURANCE ISSUE 34 0.0022
395 SINUS DISORDER 44 0.0022
396 DYSGEUSIA 165 0.0022
397 SCAR 38 0.0022
398 BLADDER DISORDER 22 0.0022
399 FOOT FRACTURE 42 0.0022
400 DYSPHAGIA 210 0.0022
401 UPPER RESPIRATORY TRACT INFECTION 102 0.0022
402 MEMORY IMPAIRMENT 302 0.0022
403 EYE PAIN 124 0.0022
404 TREATMENT FAILURE 182 0.0022
405 ANKLE FRACTURE 34 0.0022
406 MULTIPLE SCLEROSIS 105 0.0022
407 SMALL INTESTINAL OBSTRUCTION 27 0.0022
408 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 105 0.0022
409 MYOCLONUS 26 0.0022
410 PHOTOSENSITIVITY REACTION 36 0.0022
411 NERVOUS SYSTEM DISORDER 68 0.0022
412 EMOTIONAL DISORDER 67 0.0022
413 IRON DEFICIENCY ANAEMIA 20 0.0022
414 URINARY INCONTINENCE 64 0.0022
415 EXTRASYSTOLES 15 0.0021
416 SEIZURE 248 0.0021
417 DISORIENTATION 85 0.0021
418 DYSKINESIA 87 0.0021
419 VITREOUS FLOATERS 21 0.0021
420 INFUSION SITE ERYTHEMA 18 0.0021
421 CONFUSIONAL STATE 345 0.0021
422 INTENTIONAL SELF-INJURY 43 0.0021
423 POOR VENOUS ACCESS 22 0.0021
424 CONSTIPATION 462 0.0021
425 COVID-19 PNEUMONIA 25 0.0021
426 BACK INJURY 23 0.0021
427 CONTUSION 203 0.0021
428 RHINITIS 17 0.0021
429 CHOLELITHIASIS 69 0.0021
430 HEART RATE INCREASED 208 0.0021
431 SLEEP DISORDER 148 0.0021
432 MUSCULAR WEAKNESS 238 0.0021
433 SYNCOPE 209 0.0021
434 APPLICATION SITE PAIN 46 0.0021
435 MATERNAL DRUGS AFFECTING FOETUS 16 0.0021
436 DISABILITY 41 0.0021
437 DERMATITIS BULLOUS 15 0.0021
438 NERVE INJURY 23 0.0021
439 DERMATITIS ALLERGIC 26 0.0021
440 PSYCHOTIC DISORDER 61 0.0021
441 DIZZINESS POSTURAL 20 0.0021
442 LYMPHADENOPATHY 73 0.0021
443 FLUSHING 209 0.0021
444 BEDRIDDEN 27 0.0021
445 INTERVERTEBRAL DISC DEGENERATION 19 0.0021
446 OSTEOARTHRITIS 87 0.0021
447 AUTOIMMUNE DISORDER 20 0.0020
448 TOOTH INFECTION 27 0.0020
449 PAIN 1258 0.0020
450 FEELING JITTERY 39 0.0020
451 TOOTHACHE 37 0.0020
452 HEMIPLEGIA 17 0.0020
453 HALLUCINATION 154 0.0020
454 ABDOMINAL PAIN 474 0.0020
455 APPENDICITIS 19 0.0020
456 THROAT IRRITATION 91 0.0020
457 ARTHROPOD BITE 15 0.0020
458 OROPHARYNGEAL PAIN 187 0.0020
459 INJECTION SITE BRUISING 161 0.0020
460 RETCHING 43 0.0020
461 DEEP VEIN THROMBOSIS 131 0.0020
462 PRODUCT PRESCRIBING ERROR 48 0.0020
463 CONTRAINDICATED PRODUCT ADMINISTERED 61 0.0020
464 JOINT INJURY 43 0.0020
465 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
466 PETECHIAE 21 0.0020
467 APPLICATION SITE IRRITATION 25 0.0020
468 CIRCULATORY COLLAPSE 34 0.0020
469 BREAST TENDERNESS 15 0.0020
470 HEAD INJURY 63 0.0020
471 HYPOAESTHESIA ORAL 30 0.0020
472 VITAMIN D DECREASED 17 0.0020
473 INCONTINENCE 21 0.0020
474 AMNESIA 129 0.0020
475 LOSS OF CONSCIOUSNESS 254 0.0020
476 MUSCLE DISORDER 16 0.0020
477 FATIGUE 1538 0.0020
478 OSTEOPOROSIS 81 0.0020
479 SARS-COV-2 TEST POSITIVE 26 0.0020
480 CEREBRAL INFARCTION 48 0.0020
481 SUBARACHNOID HAEMORRHAGE 20 0.0020
482 INTENTIONAL PRODUCT MISUSE 171 0.0020
483 DEVICE MALFUNCTION 137 0.0019
484 SPINAL OPERATION 24 0.0019
485 SEDATION 51 0.0019
486 APPLICATION SITE ERYTHEMA 51 0.0019
487 ARTHRITIS 153 0.0019
488 NAIL DISORDER 17 0.0019
489 HAIR DISORDER 16 0.0019
490 ILLNESS 200 0.0019
491 UNRESPONSIVE TO STIMULI 50 0.0019
492 SPINAL OSTEOARTHRITIS 17 0.0019
493 URTICARIA 324 0.0019
494 AGITATION 142 0.0019
495 PELVIC FRACTURE 15 0.0019
496 SINUS CONGESTION 26 0.0019
497 INJURY 135 0.0019
498 INFLUENZA LIKE ILLNESS 158 0.0019
499 INJECTION SITE URTICARIA 47 0.0019
500 HEART RATE DECREASED 67 0.0019
501 GINGIVAL BLEEDING 26 0.0019
502 HEART RATE IRREGULAR 43 0.0019
503 ORAL CANDIDIASIS 25 0.0019
504 FEAR 51 0.0019
505 RIB FRACTURE 39 0.0019
506 GASTRIC ULCER 36 0.0019
507 PREMATURE BABY 57 0.0019
508 ANGER 64 0.0019
509 DRUG INEFFECTIVE 2492 0.0019
510 ANAL INCONTINENCE 17 0.0019
511 ROAD TRAFFIC ACCIDENT 79 0.0019
512 SYNOVITIS 34 0.0019
513 RENAL INJURY 56 0.0019
514 HYPOKALAEMIA 87 0.0019
515 MANIA 31 0.0019
516 INCREASED APPETITE 36 0.0019
517 MALNUTRITION 21 0.0019
518 PULMONARY EMBOLISM 178 0.0019
519 BLOOD PRESSURE INCREASED 286 0.0019
520 MUSCLE SPASMS 343 0.0019
521 THERAPY NON-RESPONDER 84 0.0019
522 TOOTH ABSCESS 19 0.0019
523 HYPOKINESIA 27 0.0019
524 ABDOMINAL DISTENSION 194 0.0019
525 RHINORRHOEA 120 0.0019
526 INTENTIONAL OVERDOSE 119 0.0019
527 NEUROLEPTIC MALIGNANT SYNDROME 22 0.0019
528 PRODUCT DOSE OMISSION ISSUE 544 0.0018
529 CHOLECYSTITIS 22 0.0018
530 IRRITABILITY 111 0.0018
531 PRODUCTIVE COUGH 88 0.0018
532 MUSCLE RIGIDITY 22 0.0018
533 TRANSIENT ISCHAEMIC ATTACK 62 0.0018
534 KIDNEY INFECTION 36 0.0018
535 BRADYCARDIA 97 0.0018
536 ASPIRATION 20 0.0018
537 THINKING ABNORMAL 34 0.0018
538 VISUAL IMPAIRMENT 226 0.0018
539 ANAPHYLACTIC SHOCK 47 0.0018
540 DYSMENORRHOEA 24 0.0018
541 MADAROSIS 21 0.0018
542 LETHARGY 104 0.0018
543 RESPIRATORY RATE INCREASED 16 0.0018
544 URINARY TRACT INFECTION 307 0.0018
545 MEDICATION ERROR 100 0.0018
546 BLOOD POTASSIUM DECREASED 54 0.0018
547 CHOKING 35 0.0018
548 MALAISE 786 0.0018
549 BLOOD PRESSURE FLUCTUATION 43 0.0018
550 GASTRITIS 47 0.0018
551 HYPOTHYROIDISM 57 0.0018
552 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
553 ALOPECIA 349 0.0018
554 POLLAKIURIA 74 0.0018
555 SURGERY 104 0.0018
556 BACK PAIN 412 0.0018
557 LEUKOCYTOSIS 32 0.0018
558 INJECTION SITE HAEMORRHAGE 141 0.0018
559 ARTHRALGIA 734 0.0018
560 SLUGGISHNESS 18 0.0018
561 RESPIRATORY TRACT CONGESTION 28 0.0018
562 SINUS BRADYCARDIA 17 0.0018
563 PRESCRIBED UNDERDOSE 35 0.0018
564 DRUG ABUSE 146 0.0018
565 PSORIATIC ARTHROPATHY 71 0.0017
566 ABDOMINAL PAIN UPPER 360 0.0017
567 SYSTEMIC LUPUS ERYTHEMATOSUS 62 0.0017
568 RENAL TUBULAR NECROSIS 17 0.0017
569 PRODUCT DOSE OMISSION IN ERROR 49 0.0017
570 LIMB INJURY 47 0.0017
571 APHONIA 24 0.0017
572 HAIR TEXTURE ABNORMAL 23 0.0017
573 PRODUCT USE IN UNAPPROVED INDICATION 426 0.0017
574 COVID-19 301 0.0017
575 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29 0.0017
576 LACERATION 16 0.0017
577 PREGNANCY 34 0.0017
578 VENTRICULAR TACHYCARDIA 28 0.0017
579 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
580 SCIATICA 27 0.0017
581 CYST 21 0.0017
582 MENTAL IMPAIRMENT 41 0.0017
583 EATING DISORDER 36 0.0017
584 METABOLIC ACIDOSIS 54 0.0017
585 NASOPHARYNGITIS 311 0.0017
586 WEIGHT INCREASED 377 0.0017
587 POISONING 21 0.0017
588 IMMUNE SYSTEM DISORDER 22 0.0017
589 LOSS OF LIBIDO 15 0.0017
590 ACUTE RESPIRATORY FAILURE 32 0.0017
591 PHARYNGITIS STREPTOCOCCAL 18 0.0017
592 MUSCULOSKELETAL PAIN 87 0.0017
593 MYOCARDITIS 19 0.0017
594 COMPLETED SUICIDE 138 0.0017
595 MENTAL DISORDER 72 0.0017
596 TUBULOINTERSTITIAL NEPHRITIS 31 0.0017
597 SUICIDE ATTEMPT 100 0.0016
598 MUCOSAL INFLAMMATION 43 0.0016
599 DYSPNOEA 929 0.0016
600 LYMPHOCYTE COUNT DECREASED 29 0.0016
601 HYPERSOMNIA 47 0.0016
602 ULCER 26 0.0016
603 INTENTIONAL PRODUCT USE ISSUE 143 0.0016
604 INJECTION SITE PRURITUS 109 0.0016
605 MUSCULOSKELETAL CHEST PAIN 25 0.0016
606 DRUG EFFECT DECREASED 87 0.0016
607 PERSONALITY CHANGE 15 0.0016
608 LOWER LIMB FRACTURE 31 0.0016
609 HALLUCINATION, VISUAL 34 0.0016
610 GAIT DISTURBANCE 308 0.0016
611 ORAL PAIN 36 0.0016
612 DYSPEPSIA 158 0.0016
613 INJECTION SITE SWELLING 123 0.0016
614 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
615 HERNIA 31 0.0016
616 EPILEPSY 49 0.0016
617 BACK DISORDER 26 0.0016
618 INJECTION SITE REACTION 110 0.0016
619 EYE INFECTION 18 0.0016
620 ASTHENIA 599 0.0016
621 BONE DISORDER 29 0.0016
622 NERVOUSNESS 83 0.0016
623 PERIPHERAL SWELLING 244 0.0016
624 AGGRESSION 79 0.0016
625 FEEDING DISORDER 32 0.0016
626 DYSURIA 58 0.0016
627 MOTOR DYSFUNCTION 16 0.0016
628 MENSTRUATION DELAYED 17 0.0016
629 DEPRESSED LEVEL OF CONSCIOUSNESS 62 0.0016
630 BURSITIS 19 0.0016
631 NOCTURIA 19 0.0016
632 INJECTION SITE PAIN 480 0.0016
633 ABDOMINAL DISCOMFORT 262 0.0016
634 PRODUCT PRESCRIBING ISSUE 34 0.0016
635 EYE DISORDER 51 0.0015
636 PROCEDURAL PAIN 43 0.0015
637 BLOOD CHOLESTEROL INCREASED 72 0.0015
638 WEIGHT DECREASED 431 0.0015
639 INTENTIONAL DOSE OMISSION 44 0.0015
640 TOOTH FRACTURE 17 0.0015
641 PELVIC PAIN 28 0.0015
642 PAIN IN EXTREMITY 453 0.0015
643 ACUTE KIDNEY INJURY 235 0.0015
644 INFLUENZA 171 0.0015
645 CARDIOGENIC SHOCK 22 0.0015
646 SKIN LESION 42 0.0015
647 RESTLESSNESS 56 0.0015
648 BODY TEMPERATURE DECREASED 15 0.0015
649 CONDITION AGGRAVATED 463 0.0015
650 DEHYDRATION 203 0.0015
651 SWELLING 142 0.0015
652 INJECTION SITE MASS 56 0.0015
653 FALL 504 0.0015
654 INABILITY TO AFFORD MEDICATION 15 0.0015
655 DYSSTASIA 44 0.0015
656 STATUS EPILEPTICUS 17 0.0015
657 THROMBOSIS 121 0.0015
658 EMOTIONAL DISTRESS 182 0.0015
659 VIRAL INFECTION 50 0.0015
660 HYPOTENSION 301 0.0015
661 JOINT SWELLING 181 0.0015
662 RENAL FAILURE 199 0.0015
663 BLOOD TEST ABNORMAL 21 0.0015
664 SCAB 17 0.0015
665 LIVER FUNCTION TEST INCREASED 32 0.0015
666 RASH MACULAR 52 0.0015
667 TENDONITIS 23 0.0015
668 EXPIRED PRODUCT ADMINISTERED 49 0.0015
669 RASH PAPULAR 33 0.0015
670 SKIN LACERATION 16 0.0015
671 INJECTION SITE INDURATION 19 0.0015
672 WOUND INFECTION 16 0.0015
673 OFF LABEL USE 1279 0.0015
674 C-REACTIVE PROTEIN INCREASED 53 0.0015
675 PSORIASIS 190 0.0015
676 VAGINAL HAEMORRHAGE 63 0.0015
677 RESPIRATORY ARREST 40 0.0014
678 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
679 HEPATIC STEATOSIS 27 0.0014
680 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
681 THERAPY CESSATION 74 0.0014
682 SKIN DISCOLOURATION 66 0.0014
683 BLOOD IRON DECREASED 17 0.0014
684 THYROID DISORDER 22 0.0014
685 HERPES ZOSTER 82 0.0014
686 OCULAR DISCOMFORT 16 0.0014
687 ACCIDENTAL OVERDOSE 52 0.0014
688 MUSCLE ATROPHY 18 0.0014
689 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
690 MOBILITY DECREASED 102 0.0014
691 ACTIVITIES OF DAILY LIVING IMPAIRED 28 0.0014
692 TOXICITY TO VARIOUS AGENTS 238 0.0014
693 SKIN DISORDER 47 0.0014
694 DECREASED APPETITE 327 0.0014
695 PRURITUS 541 0.0014
696 BRONCHOSPASM 20 0.0014
697 MOVEMENT DISORDER 45 0.0014
698 PRODUCT USE COMPLAINT 22 0.0014
699 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
700 ACCIDENTAL UNDERDOSE 20 0.0014
701 PRODUCT ADMINISTRATION ERROR 28 0.0014
702 ABDOMINAL PAIN LOWER 35 0.0014
703 HYPERTHYROIDISM 20 0.0014
704 FUNGAL INFECTION 46 0.0014
705 NODULE 18 0.0014
706 POST PROCEDURAL HAEMORRHAGE 16 0.0014
707 CAESAREAN SECTION 16 0.0014
708 BLINDNESS 56 0.0014
709 CHILLS 161 0.0014
710 GASTROINTESTINAL DISORDER 123 0.0014
711 DIARRHOEA 886 0.0014
712 COLITIS 52 0.0014
713 ILEUS 17 0.0014
714 INJECTION SITE ERYTHEMA 169 0.0014
715 MASS 19 0.0014
716 BLOOD PRESSURE ABNORMAL 27 0.0014
717 SECRETION DISCHARGE 17 0.0014
718 POST PROCEDURAL COMPLICATION 26 0.0014
719 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
720 DELUSION 21 0.0014
721 METRORRHAGIA 23 0.0013
722 UNEVALUABLE EVENT 102 0.0013
723 CONJUNCTIVITIS 25 0.0013
724 CARDIAC ARREST 111 0.0013
725 HAEMATEMESIS 34 0.0013
726 HAEMATOCHEZIA 74 0.0013
727 COUGH 375 0.0013
728 INJECTION SITE RASH 41 0.0013
729 DIVERTICULITIS 37 0.0013
730 WHEEZING 79 0.0013
731 RHEUMATOID ARTHRITIS 151 0.0013
732 NEUROPATHY PERIPHERAL 125 0.0013
733 ABNORMAL DREAMS 36 0.0013
734 BONE PAIN 76 0.0013
735 INCORRECT DOSE ADMINISTERED BY DEVICE 34 0.0013
736 ABNORMAL WEIGHT GAIN 16 0.0013
737 VISUAL ACUITY REDUCED 43 0.0013
738 DRUG EFFECT INCOMPLETE 47 0.0013
739 DRUG EXPOSURE DURING PREGNANCY 44 0.0013
740 AGRANULOCYTOSIS 24 0.0013
741 GAIT INABILITY 43 0.0013
742 EPISTAXIS 96 0.0013
743 DEVICE BREAKAGE 52 0.0013
744 SKIN ULCER 33 0.0013
745 PULMONARY MASS 19 0.0013
746 GASTROENTERITIS VIRAL 23 0.0013
747 INFUSION RELATED REACTION 84 0.0013
748 HALLUCINATION, AUDITORY 20 0.0013
749 ACCIDENT 15 0.0013
750 MACULAR DEGENERATION 15 0.0013
751 UPPER LIMB FRACTURE 25 0.0013
752 ABSCESS 20 0.0013
753 ACCIDENTAL EXPOSURE TO PRODUCT 129 0.0013
754 GLAUCOMA 24 0.0012
755 RASH 542 0.0012
756 DRUG DISPENSING ERROR 19 0.0012
757 STAPHYLOCOCCAL INFECTION 41 0.0012
758 LEUKOPENIA 62 0.0012
759 DYSTONIA 24 0.0012
760 EYE SWELLING 46 0.0012
761 APATHY 18 0.0012
762 TASTE DISORDER 25 0.0012
763 PAIN OF SKIN 33 0.0012
764 ENCEPHALOPATHY 30 0.0012
765 BASAL CELL CARCINOMA 19 0.0012
766 PYREXIA 421 0.0012
767 INJECTION SITE WARMTH 25 0.0012
768 HYPOPHAGIA 31 0.0012
769 GENERALISED OEDEMA 15 0.0012
770 PANCREATITIS 64 0.0012
771 DRUG LEVEL INCREASED 20 0.0012
772 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
773 ADVERSE DRUG REACTION 108 0.0012
774 PANCREATITIS ACUTE 27 0.0012
775 PNEUMOTHORAX 19 0.0012
776 HAEMATOMA 31 0.0012
777 UNDERDOSE 87 0.0012
778 CELLULITIS 60 0.0012
779 EYE PRURITUS 40 0.0012
780 BLOOD PRESSURE DECREASED 79 0.0012
781 SUBDURAL HAEMATOMA 17 0.0012
782 ECZEMA 62 0.0012
783 DISEASE RECURRENCE 56 0.0012
784 HEPATITIS 30 0.0012
785 CONVULSION 67 0.0012
786 TRANSAMINASES INCREASED 26 0.0012
787 DRUG RESISTANCE 30 0.0012
788 GASTROENTERITIS 17 0.0012
789 DEVICE DIFFICULT TO USE 77 0.0012
790 LACRIMATION INCREASED 35 0.0012
791 MENINGIOMA 18 0.0012
792 THERAPY INTERRUPTED 82 0.0011
793 LOCAL SWELLING 20 0.0011
794 CYANOSIS 18 0.0011
795 RASH PRURITIC 62 0.0011
796 IMMUNODEFICIENCY 17 0.0011
797 HAEMORRHAGE INTRACRANIAL 17 0.0011
798 GASTRIC DISORDER 39 0.0011
799 LIVER FUNCTION TEST ABNORMAL 33 0.0011
800 BLOOD UREA INCREASED 19 0.0011
801 TYPE 2 DIABETES MELLITUS 38 0.0011
802 NEUTROPHIL COUNT DECREASED 46 0.0011
803 STEVENS-JOHNSON SYNDROME 25 0.0011
804 BLISTER 63 0.0011
805 MENSTRUATION IRREGULAR 30 0.0011
806 MALIGNANT MELANOMA 15 0.0011
807 RED BLOOD CELL COUNT DECREASED 32 0.0011
808 BONE DENSITY DECREASED 35 0.0011
809 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 226 0.0011
810 INTESTINAL OBSTRUCTION 42 0.0011
811 PRURITUS GENERALISED 24 0.0011
812 HAEMATOCRIT DECREASED 22 0.0011
813 ERYTHEMA 228 0.0011
814 CHROMATURIA 25 0.0011
815 MUSCULOSKELETAL DISORDER 21 0.0011
816 INJECTION SITE HAEMATOMA 16 0.0011
817 PRODUCT DISPENSING ERROR 24 0.0011
818 LOWER RESPIRATORY TRACT INFECTION 50 0.0011
819 SPINAL FRACTURE 22 0.0011
820 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
821 CORONARY ARTERY OCCLUSION 15 0.0011
822 CARDIOMYOPATHY 16 0.0011
823 MENTAL STATUS CHANGES 30 0.0011
824 SKIN HAEMORRHAGE 16 0.0011
825 HUNGER 15 0.0011
826 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 56 0.0011
827 INFECTION 155 0.0011
828 UPPER GASTROINTESTINAL HAEMORRHAGE 18 0.0011
829 FACE OEDEMA 18 0.0011
830 IMPAIRED HEALING 35 0.0011
831 ALANINE AMINOTRANSFERASE INCREASED 65 0.0011
832 APPLICATION SITE PRURITUS 24 0.0011
833 HIP FRACTURE 34 0.0011
834 RENAL DISORDER 49 0.0011
835 PNEUMONIA 340 0.0010
836 DERMATITIS 22 0.0010
837 SHOCK 24 0.0010
838 PRODUCT USE ISSUE 196 0.0010
839 FLUID RETENTION 53 0.0010
840 HEPATIC ENZYME INCREASED 71 0.0010
841 LUNG DISORDER 51 0.0010
842 RESPIRATORY DISORDER 31 0.0010
843 ABNORMAL BEHAVIOUR 41 0.0010
844 MULTIPLE FRACTURES 17 0.0010
845 TOOTH DISORDER 23 0.0010
846 OEDEMA PERIPHERAL 126 0.0010
847 PRESCRIBED OVERDOSE 20 0.0010
848 CEREBRAL HAEMORRHAGE 37 0.0010
849 PALLOR 28 0.0010
850 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
851 HAEMORRHOIDS 20 0.0010
852 RECTAL HAEMORRHAGE 44 0.0010
853 DEVICE DELIVERY SYSTEM ISSUE 28 0.0010
854 DRUG-INDUCED LIVER INJURY 32 0.0010
855 MYOCARDIAL INFARCTION 177 0.0010
856 RESPIRATORY DISTRESS 28 0.0010
857 PULMONARY HYPERTENSION 21 0.0010
858 CEREBROVASCULAR ACCIDENT 169 0.0010
859 KNEE ARTHROPLASTY 21 0.0010
860 HYPOGLYCAEMIA 48 0.0010
861 ARTHROPATHY 55 0.0010
862 CHOLESTASIS 19 0.0010
863 FLATULENCE 56 0.0010
864 OVERDOSE 213 0.0010
865 GENERAL PHYSICAL HEALTH DETERIORATION 113 0.0010
866 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 176 0.0010
867 SKIN CANCER 21 0.0010
868 DEVICE RELATED INFECTION 15 0.0010
869 BLOOD CREATINE PHOSPHOKINASE INCREASED 28 0.0010
870 ILL-DEFINED DISORDER 59 0.0010
871 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
872 SEPSIS 108 0.0010
873 FREQUENT BOWEL MOVEMENTS 26 0.0010
874 OEDEMA 52 0.0010
875 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
876 PRODUCT STORAGE ERROR 83 0.0009
877 PROTEINURIA 18 0.0009
878 GLOSSODYNIA 21 0.0009
879 ERECTILE DYSFUNCTION 24 0.0009
880 HAEMATURIA 32 0.0009
881 WOUND 26 0.0009
882 TOOTH LOSS 19 0.0009
883 INCORRECT DOSE ADMINISTERED 209 0.0009
884 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
885 RHABDOMYOLYSIS 38 0.0009
886 INFLAMMATION 47 0.0009
887 STOMATITIS 55 0.0009
888 CATARACT 54 0.0009
889 COMPLICATION OF DEVICE INSERTION 18 0.0009
890 HYPOCALCAEMIA 17 0.0009
891 GOUT 16 0.0009
892 ADVERSE EVENT 82 0.0009
893 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30 0.0009
894 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
895 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 16 0.0009
896 DERMATITIS ATOPIC 46 0.0009
897 PRODUCT COMPLAINT 22 0.0009
898 MENORRHAGIA 17 0.0009
899 DELIRIUM 30 0.0009
900 LIVER DISORDER 38 0.0009
901 DRUG WITHDRAWAL SYNDROME 75 0.0009
902 DIABETES MELLITUS 65 0.0009
903 ASCITES 25 0.0008
904 ABASIA 21 0.0008
905 ANAEMIA 162 0.0008
906 BLOOD TRIGLYCERIDES INCREASED 15 0.0008
907 ARRHYTHMIA 40 0.0008
908 BLOOD URINE PRESENT 16 0.0008
909 PRODUCT ADHESION ISSUE 30 0.0008
910 EYE IRRITATION 48 0.0008
911 ASPARTATE AMINOTRANSFERASE INCREASED 44 0.0008
912 PRODUCT PREPARATION ERROR 17 0.0008
913 BREAST CANCER FEMALE 22 0.0008
914 ACNE 62 0.0008
915 BACTERIAL INFECTION 15 0.0008
916 LACTIC ACIDOSIS 26 0.0008
917 EXTRA DOSE ADMINISTERED 32 0.0008
918 LOCALISED INFECTION 19 0.0008
919 BREAST CANCER 73 0.0008
920 DRUG ADMINISTRATION ERROR 24 0.0008
921 DRY SKIN 103 0.0008
922 CARDIAC DISORDER 72 0.0008
923 HYPONATRAEMIA 43 0.0008
924 DEVICE LEAKAGE 33 0.0008
925 RASH ERYTHEMATOUS 36 0.0008
926 TREATMENT NONCOMPLIANCE 41 0.0007
927 PRODUCT AVAILABILITY ISSUE 17 0.0007
928 LABORATORY TEST ABNORMAL 22 0.0007
929 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
930 FEMUR FRACTURE 23 0.0007
931 DRUG DOSE OMISSION BY DEVICE 58 0.0007
932 PLEURAL EFFUSION 45 0.0007
933 COLITIS ULCERATIVE 33 0.0007
934 PERICARDIAL EFFUSION 17 0.0007
935 DRUG DEPENDENCE 117 0.0007
936 CORONARY ARTERY DISEASE 22 0.0007
937 RENAL IMPAIRMENT 61 0.0007
938 HYPOACUSIS 31 0.0007
939 HAEMORRHAGE 75 0.0007
940 OCULAR HYPERAEMIA 34 0.0007
941 HOSPITALISATION 110 0.0007
942 THROMBOCYTOPENIA 80 0.0007
943 PULMONARY OEDEMA 32 0.0007
944 HYPERGLYCAEMIA 26 0.0007
945 OXYGEN SATURATION DECREASED 40 0.0007
946 HYPOXIA 25 0.0007
947 FAECES DISCOLOURED 15 0.0007
948 BLOOD CREATININE INCREASED 45 0.0007
949 SKIN EXFOLIATION 58 0.0007
950 AGEUSIA 17 0.0007
951 INCORRECT DRUG ADMINISTRATION DURATION 19 0.0007
952 DIABETIC KETOACIDOSIS 16 0.0007
953 HEPATIC FAILURE 20 0.0007
954 PNEUMONITIS 18 0.0007
955 COMA 31 0.0007
956 CARDIO-RESPIRATORY ARREST 27 0.0006
957 OSTEONECROSIS 21 0.0006
958 RENAL FAILURE ACUTE 27 0.0006
959 CARDIOVASCULAR DISORDER 16 0.0006
960 SKIN BURNING SENSATION 45 0.0006
961 RESPIRATORY FAILURE 45 0.0006
962 HEPATIC FUNCTION ABNORMAL 23 0.0006
963 SKIN IRRITATION 28 0.0006
964 HAEMOGLOBIN DECREASED 61 0.0006
965 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 27 0.0006
967 ATRIAL FIBRILLATION 56 0.0006
968 BLOOD BILIRUBIN INCREASED 15 0.0006
969 DEVICE USE ERROR 19 0.0005
970 HAEMOPTYSIS 15 0.0005
971 NEUTROPENIA 73 0.0005
972 DEVICE DISLOCATION 22 0.0005
973 SEPTIC SHOCK 22 0.0005
974 BLOOD GLUCOSE DECREASED 24 0.0005
975 NEOPLASM MALIGNANT 33 0.0005
976 BLOOD GLUCOSE INCREASED 87 0.0005
977 INCORRECT ROUTE OF DRUG ADMINISTRATION 16 0.0004
978 PLATELET COUNT DECREASED 47 0.0004
979 FEBRILE NEUTROPENIA 29 0.0004
980 PANCYTOPENIA 24 0.0004
981 DEVICE EXPULSION 27 0.0004
982 PLASMA CELL MYELOMA 16 0.0004
983 NO ADVERSE EVENT 72 0.0004
984 CARDIAC FAILURE 29 0.0004
985 CARDIAC FAILURE CONGESTIVE 29 0.0004
986 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
987 DEPENDENCE 17 0.0003
988 DISEASE PROGRESSION 34 0.0003
989 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
990 DEATH 218 0.0003